# The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

> **NCT04741386** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 854 (actual)

## Conditions studied

- Covid19
- Chronic Kidney Diseases

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 vaccination

## Key facts

- **NCT ID:** NCT04741386
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-17
- **Primary completion:** 2021-06-04
- **Final completion:** 2022-02-25
- **Target enrollment:** 854 (ACTUAL)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04741386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04741386, "The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04741386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*